Ambeed.cn

首页 / 抑制剂/激动剂 / 细胞骨架 / / ML-9

ML-9 {[allProObj[0].p_purity_real_show]}

货号:A439969 同义名: ML-9 HCl; ML-9 hydrochloride

ML-9 是一种肌球蛋白轻链激酶(MLCK)抑制剂,可增强紫杉醇的抗癌活性,通过双重抑制 Akt 通路和自噬作用发挥潜在抗癌效果,常用于癌症的研究。

ML-9 化学结构 CAS号:105637-50-1
ML-9 化学结构
CAS号:105637-50-1
ML-9 3D分子结构
CAS号:105637-50-1
ML-9 化学结构 CAS号:105637-50-1
ML-9 3D分子结构 CAS号:105637-50-1
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

ML-9 纯度/质量文件 产品仅供科研

货号:A439969 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

ML-9 生物活性

靶点
  • Calcium Channel

描述 The Ca2+/calmodulin-dependent myosin light-chain kinase (MLCK) pathway is considered the primary regulatory pathway for contraction of airway smooth muscle. ML-9 is a membrane-permeable organic substance that has been identified as an inhibitor of MLCK. ML-9 at a concentration of 30 or 100μM inhibited Ca2+ mobilization induced by a high concentration of K+, methacholine, and thapsigargin in guinea pig tracheal smooth muscle.[2] ML-9 at 30μM reduced the phosphorylation of Akt in lymph node carcinoma of the prostate (LNCaP) cells. Treatment with ML-9 (1 – 50μM, 2 – 24h) also dose- and time-dependently increased the expression level of LC3-II in LNCaP cells. Treatment of LNCaP cells with 30μM ML-9 for 24h significantly induced prostate cancer cell death.[1]
作用机制 ML-9 is a membrane-permeable organic substance that has been identified as an inhibitor of MLCK, Akt kinase, and stromal interaction molecule 1.[1]

ML-9 细胞实验

Cell Line
Concentration Treated Time Description References
Human neutrophils 0–117 µM 1 hour To evaluate the effect of ML-9 on intracellular calcium concentration in human neutrophils. Results showed that ML-9 enhanced the thapsigargin-induced increase in intracellular calcium levels, suggesting ML-9 may affect calcium flux through mechanisms other than SOCE. Cells. 2018 Nov 9;7(11):204.
LNCaP cells 30 µM 12 hours ML-9 inhibits Akt phosphorylation, reduces mTOR activity, increases LC3-II levels, and induces autophagosome accumulation. Cell Death Dis. 2014 Apr 24;5(4):e1193.
HEK293 cells 100 µM 5 minutes To evaluate the inhibitory effects of ML-9 on SOCE and EYFP-Stim1 rearrangement. Results showed that ML-9 nearly completely inhibited SOCE and prevented the formation of punctate EYFP-Stim1 structures near the plasma membrane. J Cell Sci. 2008 Mar 15;121(Pt 6):762-72.
HEK293 cells 7.8 µM (IC50) 5 seconds ML-9 inhibits TRPC6 channels via a mechanism independent of MLCK activity, acting directly on the TRPC6 channel itself. Br J Pharmacol. 2007 Sep;152(1):122-31.
3T3-L1 adipocytes 50 µM 90 minutes To investigate the effect of ML-9 on metabolic stress and insulin-stimulated glucose uptake, results showed that ML-9 inhibited azide- and insulin-stimulated glucose uptake. Biochem J. 1995 Aug 1;309 ( Pt 3)(Pt 3):731-6.
Clone9 cells 50 µM 90 minutes To investigate the effect of ML-9 on metabolic stress and insulin-stimulated glucose uptake, results showed that ML-9 inhibited azide- and insulin-stimulated glucose uptake. Biochem J. 1995 Aug 1;309 ( Pt 3)(Pt 3):731-6.

ML-9 参考文献

[1]Kondratskyi A, Yassine M, Slomianny C, Kondratska K, Gordienko D, Dewailly E, Lehen'kyi V, Skryma R, Prevarskaya N. Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death. Cell Death Dis. 2014 Apr 24;5(4):e1193. doi: 10.1038/cddis.2014.156

[2]Ito S, Kume H, Honjo H, Kodama I, Katoh H, Hayashi H, Shimokata K. ML-9, a myosin light chain kinase inhibitor, reduces intracellular Ca2+ concentration in guinea pig trachealis. Eur J Pharmacol. 2004 Feb 23;486(3):325-33. doi: 10.1016/j.ejphar.2004.01.013

ML-9 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.77mL

0.55mL

0.28mL

13.84mL

2.77mL

1.38mL

27.68mL

5.54mL

2.77mL

ML-9 技术信息

CAS号105637-50-1
分子式C15H18Cl2N2O2S
分子量 361.29
SMILES Code O=S(N1CCNCCC1)(C2=C3C=CC=C(Cl)C3=CC=C2)=O.[H]Cl
MDL No. MFCD00065525
别名 ML-9 HCl; ML-9 hydrochloride
运输蓝冰
InChI Key ZNRYCIVTNLZOGI-UHFFFAOYSA-N
Pubchem ID 108047
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 85 mg/mL(235.27 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 5 mg/mL(13.84 mM)

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。